SELANK AMIDATE

N-Acetyl Selank Amidate is a chemically modified version of Selank in which the N-terminal is acetylated and the C-terminal is amidated. These structural modifications significantly improve metabolic stability and bioavailability, and extend the compound's half-life compared to standard Selank. Research suggests it is a more potent and longer-acting variant for anxiolytic and nootropic biology studies.

Mechanism of Action

•        N-terminal acetylation studied for protection against amino-peptidase degradation, extending plasma half-life in research models.

•        C-terminal amidation investigated for prevention of carboxypeptidase degradation and improved receptor affinity.

•        Modulates GABAergic, serotonergic, and dopaminergic neurotransmission with greater potency than standard Selank in preclinical models.

•        Research shows more robust BDNF elevation than the unmodified form, supporting enhanced neuroplasticity studies.

•        Investigated for inhibition of enkephalin-degrading enzymes to prolong endogenous neuropeptide activity.

Research Areas

•        Anxiety and stress resilience research with extended duration of action per research cycle.

•        Cognitive biology including memory, focus, and processing speed studies.

•        Mood disorder research and emotional regulation biology.

•        Comparative pharmacokinetic studies between Selank and its modified analog.

Presentation and Storage

Supplied as a lyophilized powder in a sealed vial containing 10mg of N-Acetyl Selank Amidate. Reconstitute with bacteriostatic water for laboratory use. Store at -20C.